These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 7653447)

  • 1. Design features and baseline characteristics of the LIPID (Long-Term Intervention with Pravastatin in Ischemic Disease) Study: a randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris.
    Am J Cardiol; 1995 Sep; 76(7):474-9. PubMed ID: 7653447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
    Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
    N Engl J Med; 1998 Nov; 339(19):1349-57. PubMed ID: 9841303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.
    Sacks FM; Pfeffer MA; Moye LA; Rouleau JL; Rutherford JD; Cole TG; Brown L; Warnica JW; Arnold JM; Wun CC; Davis BR; Braunwald E
    N Engl J Med; 1996 Oct; 335(14):1001-9. PubMed ID: 8801446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imputation of plasma lipid species to facilitate integration of lipidomic datasets.
    Dakic A; Wu J; Wang T; Huynh K; Mellett N; Duong T; Beyene HB; Magliano DJ; Shaw JE; Carrington MJ; Inouye M; Yang JY; Figtree GA; Curran JE; Blangero J; Simes J; ; Giles C; Meikle PJ
    Nat Commun; 2024 Feb; 15(1):1540. PubMed ID: 38378775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Type Natriuretic Peptide and Long-Term Cardiovascular Mortality in Patients With Coronary Heart Disease.
    Stewart RAH; Kirby A; White HD; Marschner SL; West M; Thompson PL; Sullivan D; Janus E; Hunt D; Kritharides L; Keech A; Simes J; Tonkin AM
    J Am Heart Assoc; 2022 Jul; 11(13):e024616. PubMed ID: 35766272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy.
    Muñoz AE; Pollarsky FD; Marino M; Cartier M; Vázquez H; Salgado P; Romero G
    World J Gastroenterol; 2021 Jul; 27(28):4639-4652. PubMed ID: 34366626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.
    Willeit P; Tschiderer L; Allara E; Reuber K; Seekircher L; Gao L; Liao X; Lonn E; Gerstein HC; Yusuf S; Brouwers FP; Asselbergs FW; van Gilst W; Anderssen SA; Grobbee DE; Kastelein JJP; Visseren FLJ; Ntaios G; Hatzitolios AI; Savopoulos C; Nieuwkerk PT; Stroes E; Walters M; Higgins P; Dawson J; Gresele P; Guglielmini G; Migliacci R; Ezhov M; Safarova M; Balakhonova T; Sato E; Amaha M; Nakamura T; Kapellas K; Jamieson LM; Skilton M; Blumenthal JA; Hinderliter A; Sherwood A; Smith PJ; van Agtmael MA; Reiss P; van Vonderen MGA; Kiechl S; Klingenschmid G; Sitzer M; Stehouwer CDA; Uthoff H; Zou ZY; Cunha AR; Neves MF; Witham MD; Park HW; Lee MS; Bae JH; Bernal E; Wachtell K; Kjeldsen SE; Olsen MH; Preiss D; Sattar N; Beishuizen E; Huisman MV; Espeland MA; Schmidt C; Agewall S; Ok E; Aşçi G; de Groot E; Grooteman MPC; Blankestijn PJ; Bots ML; Sweeting MJ; Thompson SG; Lorenz MW;
    Circulation; 2020 Aug; 142(7):621-642. PubMed ID: 32546049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention.
    Mundra PA; Barlow CK; Nestel PJ; Barnes EH; Kirby A; Thompson P; Sullivan DR; Alshehry ZH; Mellett NA; Huynh K; Jayawardana KS; Giles C; McConville MJ; Zoungas S; Hillis GS; Chalmers J; Woodward M; Wong G; Kingwell BA; Simes J; Tonkin AM; Meikle PJ;
    JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy in patients with cirrhosis.
    Wright AP; Adusumalli S; Corey KE
    Frontline Gastroenterol; 2015 Oct; 6(4):255-261. PubMed ID: 28839820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies.
    Hermans MP; Bouenizabila E; Amoussou-Guenou DK; Ahn SA; Rousseau MF
    Cardiovasc Diabetol; 2015 May; 14():60. PubMed ID: 25990410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transitioning from trials to extended follow-up studies.
    Drye LT; Casper AS; Sternberg AL; Holbrook JT; Jenkins G; Meinert CL
    Clin Trials; 2014 Dec; 11(6):635-47. PubMed ID: 25115882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study.
    Cui J; Forbes A; Kirby A; Marschner I; Simes J; Hunt D; West M; Tonkin A
    BMC Med Res Methodol; 2010 Apr; 10():27. PubMed ID: 20356409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins Activate Human PPARalpha Promoter and Increase PPARalpha mRNA Expression and Activation in HepG2 Cells.
    Seo M; Inoue I; Ikeda M; Nakano T; Takahashi S; Katayama S; Komoda T
    PPAR Res; 2008; 2008():316306. PubMed ID: 19125197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins and fibrates for preventing melanoma.
    Dellavalle RP; Drake A; Graber M; Heilig LF; Hester EJ; Johnson KR; McNealy K; Schilling L
    Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD003697. PubMed ID: 16235336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from the prospective pravastatin pooling project.
    Byington RP; Sacks FM
    Curr Atheroscler Rep; 2004 Sep; 6(5):366-74. PubMed ID: 15296703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs used in secondary prevention after myocardial infarction: case presentation.
    Maxwell S; Waring WS
    Br J Clin Pharmacol; 2000 Nov; 50(5):405-17. PubMed ID: 11069435
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke.
    Warshafsky S; Packard D; Marks SJ; Sachdeva N; Terashita DM; Kaufman G; Sang K; Deluca AJ; Peterson SJ; Frishman WH
    J Gen Intern Med; 1999 Dec; 14(12):763-74. PubMed ID: 10632823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cardiovascular extension of the Health Measurement Questionnaire.
    Martin AJ; Glasziou PP; Simes RJ
    J Epidemiol Community Health; 1999 Sep; 53(9):548-57. PubMed ID: 10562879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting patients' utilities from quality of life items: an improved scoring system for the UBQ-H.
    Martin AJ; Glasziou PP; Simes RJ; Lumley T
    Qual Life Res; 1998 Dec; 7(8):703-11. PubMed ID: 10097619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pravastatin. A reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease.
    Haria M; McTavish D
    Drugs; 1997 Feb; 53(2):299-336. PubMed ID: 9028747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.